We are pleased to highlight the collaborative efforts of RIC Biologics and Anacura in establishing anaRIC Biologics, a contract research organization (CRO) specializing in both R&D and GMP analytical services for biologics. This partnership addresses the growing need for integrated analytical solutions in the development of biologic therapies.

This collaboration exemplifies our commitment to supporting the biopharmaceutical industry with robust analytical capabilities that span the entire product lifecycle.​

Read here the full article